Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
April 28, 2022 at 01:14 pm
Share
Tianjin Ringpu Bio-Technology Co.,Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 390.81 million compared to CNY 559.91 million a year ago. Revenue was CNY 390.81 million compared to CNY 559.91 million a year ago. Net income was CNY 72.21 million compared to CNY 116.35 million a year ago. Basic earnings per share from continuing operations was CNY 0.1564 compared to CNY 0.293 a year ago. Diluted earnings per share from continuing operations was CNY 0.1564 compared to CNY 0.293 a year ago.
Tianjin Ringpu Bio-Technology Co Ltd is a China-based company serving the animal health industry. The Company's main business areas are the research and development, production and sales of veterinary biological products, veterinary pharmaceutical preparations (chemicals, traditional Chinese veterinary medicines, disinfectants, and others), veterinary raw materials, veterinary functional additives, and provision of overall prevention and control of animal diseases. The Company's products include pharmaceuticals, vaccines, disinfectants, cleaning agents, and functional additives for pigs, chickens, waterfowl, cattle, sheep and pets, and others.
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD. 
